Mobile App

Google Play Apple Store
Quarterly Brief (October-December, 2020): A Current Expert Analysis on Important HIV Clinical Decisions
Certified CME/CNE/CPE Activities
New frontiers for HIV therapy continue to be explored, as underscored by the clinical development and use of new agents, changing regimen strategies and development of long-acting novel agents. This expanding era of simplified and effective HIV therapy presents physicians with many new opportunities and challenges for providing care. To deliver state-of-the-art HIV prevention and care, healthcare providers must stay informed regularly of new clinical data and treatment recommendations in HIV.

This educational Quarterly Brief, covering data from October through December of 2020, will discuss recent data on updated HIV guidelines, ART trials, and COVID-19 and persons with HIV.

Review the activity and claim AMA, ANCC or ACPE credit/contact hour after completion of a brief pretest and posttest/evaluation.
 










Faculty Chair
Paul Sax, MD Paul Sax, MD
Clinical Director
Division of Infectious Diseases
Brigham and Women’s Hospital
Professor of Medicine
Harvard Medical School
Faculty
 Darcy Wooten, MD, MS Darcy Wooten, MD, MS
Associate Professor of Medicine
University of California, San Diego
 

20
Supported by an independent educational grant from ViiV Healthcare

Launch Date: January 20, 2021
Release Date: January 20, 2021
Expiration Date: December 31, 2021

December 31, 2021
Mini Module
6934
QuarterlyBrief_WebBanner_1158.gif
HIV